-Conference Call and Webcast Scheduled for Tuesday, January 23 at 7:30 AM ET- HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has entered into a definitive merger agreement to acquire 100% of the outstanding stock of Data Sciences […]
IPSWICH, Mass. and CAMBRIDGE, Mass. — Recognizing that tomorrow’s innovation relies on exposing the next generation to why science matters today, New England Biolabs® (NEB®) has become the primary sponsor of the LabCentral Learning Lab. LabCentral, Greater Boston’s premier co-working laboratory and launchpad for high-potential life-sciences startups, opened the new community-oriented STEM facility in the fall of 2017 as part of its […]
Arima-HiC services is selected by the prestigious G10K consortium to generate ‘near-gapless’ reference genome assemblies for all vertebrate order species (phase-1). In a second related story, Arima Genomics today launches an early access program for its rapid, robust and easy-to-use Arima-HiC kits to satisfy the high demand for Hi-C technology. San Diego, CA Arima Genomics, […]
STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN; “Applied DNA”, “the Company”), today announced it will introduce a GeoTyping™ Beta Program, for the month of February, to brands and retailers interested in identifying country-of-origin in cases of cotton fiber substitution. Applied DNA is asking those interested to provide cotton samples suspected to contain cotton […]
Extended labelling claim adds detection of three additional gene mutations to provide the most comprehensive mutation panel for GILOTRIF® Germantown, Maryland, and Hilden, Germany – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has approved a PMA supplement extending the indications for use of QIAGEN’s therascreen® EGFR […]
Singapore – Vela Diagnostics signs a license agreement with the The University of California, San Francisco (UCSF) for two technologies, known as: FLASH (Finding Low Abundance Sequences by Hybridization); and DASH (Depletion of Abundant Sequences of Hybridization) – innovative technologies for enriching rare sequences in nucleic acid libraries. This agreement provides the framework for Vela Diagnostics to use and practice the FLASH and DASH technologies […]
Collaboration to have disruptive impact on the world food supply Research Triangle Park, North Carolina, & Ness Ziona, Israel – Syngenta, a global leading agrochemical and seed company, and NRGene, the premier genomic big data company, have continued to advance their cooperation in breeding and trait discovery in key crops. Syngenta has licensed NRGene’s GenoMAGICTM, a cloud-based big data […]
CARLSBAD, Calif. — Thermo Fisher Scientific today announced it has received more than 30 orders for multiple Ion GeneStudio S5 Systems a week after launching the new line of benchtop next-generation sequencing (NGS) instruments. The sequencers have been purchased by early access laboratories for application areas ranging from cancer research to metagenomics. “We are very excited to start […]
The miVac DNA centrifugal sample concentrator from Genevac is purpose designed to efficiently remove water and organic solvents from biological samples containing nucleic acids. The compact benchtop system includes a built-in high-performance vacuum pump, concentration chamber with electromagnetic drive for quiet, maintenance-free operation, and a fixed aluminium rotor for microcentrifuge tubes. To use your miVac […]
TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced it has entered into a third statement of work for a new clinical assay development program under its Master Assay Development, Commercialization and Manufacturing Agreement with QIAGEN Manchester Limited, a wholly owned subsidiary of […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
